Bergen 9 November 2021
Reference is made to the announcement published on 5 October 2021 by Lifecare AS(the "Company") regarding the issue of 15,467,834 new shares upon completion ofa private placement of shares.
The share capital increase pertaining to the issuance of new shares under theprivate placement has now been registered with the Norwegian Register ofBusiness Enterprises. The Company's new registered share capital is NOK39,193,658.8 divided into 97,984,147 shares, each with a par value of NOK 0.4.
This is LifecareLifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
For further information, please contact:Joacim Holter, CEO, Lifecare AS, firstname.lastname@example.org, +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to section5-12 of the Norwegian Securities Trading Act.This stock exchange announcementwas published by Kine Hereid, Investor Relations at Lifecare AS, on 09.11.2021at 09.00 CET.